Moteur de recherche d’entreprises européennes
Financement de l’UE (6 602 445 €) : Offrir aux populations vulnérables une combinaison de vaccination contre le VPH et de dépistage du cancer du col de l’utérus basé sur un test de dépistage du VPH … Hor17/12/2024 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Offrir aux populations vulnérables une combinaison de vaccination contre le VPH et de dépistage du cancer du col de l’utérus basé sur un test de dépistage du VPH. Une étude hybride d’efficacité et de mise en œuvre.
HPV-FASTER-Implement aims to improve cervical cancer (CC) prevention. Although human papillomavirus (HPV) vaccination and CC screening programmes have significantly reduced mortality, they have reached a plateau because they remain largely inaccessible and underused by vulnerable populations, creating inequalities in the European healthcare system. This adds to the difficulties already faced by vulnerable populations in their efforts to maintain their mental and physical health. HPV-FASTER-Implement will create a Europe-wide knowledge framework on vulnerabilities and the health challenges they pose, as well as the tools to monitor their evolution. HPV-FASTER-Implement will work with stakeholder representatives, primarily from vulnerable populations, to identify context-specific strategies to deliver combined HPV vaccines and HPV-based CC screening to eligible vulnerable populations, thereby reducing the burden of CC in Europe. HPV-FASTER-Implement will develop health education interventions, communication activities and other services to meet the need of vulnerable population with high risk of CC and inadequate access to health services. Through stakeholder engagement, health literacy promotion, mathematical modelling, implementation research, and vulnerability mapping, we will collect, analyse and share knowledge on gaps and opportunities to improve CC prevention in Europe, and progress FASTER towards CC elimination. We will work to ensure that the data we produce are translated into policy recommendations aimed at strengthening national prevention programmes with interventions tailored to vulnerable populations. In this way, we can leverage limited resources to rapidly reduce CC mortality. We aim to reduce health inequalities by offering an innovative prevention intervention to women at risk, with the hope that 50% of those offered the intervention will take it. HPV-FASTER-Implement will make the necessary improvements to European CC prevention policies.
| Associacio Per A La Innovacio Estrategica Vegga | 150 000 € |
| Centre Hospitalier Reg Universitaire Dijon | 0,00 € |
| Centre International de Recherche sur le Cancer | 1 049 550 € |
| European Institute of Women's Health CLG | 338 819 € |
| Inserm Transfert SA | 354 549 € |
| Institut Catala D'Oncologia | 597 531 € |
| Institut National de la Sante et de la Recherche Medicale | 953 909 € |
| Karolinska Institutet | 460 295 € |
| London School of Hygiene and Tropical Medicine Royal Charter | 631 703 € |
| Oncopole Claudius Regaud | 168 338 € |
| Region Midtjylland | 904 143 € |
| TARTU ULIKOOL | 373 017 € |
| Universitatea Babes Bolyai | 280 028 € |
| Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj-Napoca | 149 313 € |
| Universite de Toulouse | 191 250 € |
https://cordis.europa.eu/project/id/101155975
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.